Newer Targets

Researchers identify potential nanotechnology therapy for rare, incurable bone cancer

Researchers identify potential nanotechnology therapy for rare, incurable bone cancer

DCprime Presents Comprehensive Preclinical Results Supporting Lead Clinical Candidate DCP-001

DCprime Presents Comprehensive Preclinical Results Supporting Lead Clinical Candidate DCP-001

Regeneration mechanism discovered in mice could provide target for drugs to combat chronic liver...

Regeneration mechanism discovered in mice could provide target for drugs to combat chronic liver disease

New Study Demonstrates a Unique Role of Nicotinamide Riboside Over Other NAD Precursors

New Study Demonstrates a Unique Role of Nicotinamide Riboside Over Other NAD Precursors

QED and Parent Company BridgeBio Announce Preclinical Data Supporting Tolerability and Activity of Low-dose...

QED and Parent Company BridgeBio Announce Preclinical Data Supporting Tolerability and Activity of Low-dose Infigratinib in Treating Achondroplasia
- Advertisement -

LATEST NEWS

MUST READ